Pharmaceutical - Antibiotics and Infectious diseases, Pfizer

Filter

Popular Filters

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted

03-01-2014

China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

FDA issues new Boxed Warning on Pfizer antibacterial

FDA issues new Boxed Warning on Pfizer antibacterial

28-09-2013

The US Food and Drug Administration is warning that an additional analysis shows an increased risk of…

Antibiotics and Infectious diseasesNorth AmericaPfizerPharmaceuticalRegulationTygacil

Pfizer out-licenses global rights to TB drug candidate

18-07-2013

Sequella, a USA-based clinical-stage pharmaceutical company commercializing novel antibiotics to treat…

Antibiotics and Infectious diseasesLicensingPfizerPharmaceuticalSequellaSQ109sutezolid

Breakthrough status for Pfizer's palbociclib; Merck & Co Noxafil NDA accepted

11-04-2013

Global pharma behemoth Pfizer (NYSE: PFE) is the latest to gain a "Breakthrough Therapy" designation…

Antibiotics and Infectious diseasesMerck & CoNorth AmericaNoxafilOncologypalbociclibPfizerPharmaceuticalRegulation

Preliminary NICE guidance negative on Pfizer's Xalkori for lung cancer; backs Colobreathe and Tobi Podhaler for CF

27-03-2013

Much to the disappointment of the company, this morning (March 27), UK drugs watchdog the National Institute…

Antibiotics and Infectious diseasesColoBreatheEuropeForest LaboratoriesNovartisOncologyPfizerPharmaceuticalPricingRare diseasesRegulationTobi PodhalerXalkori

Merck & Co gets all clear to continue Vytorin study; FDA warns on Pfizer's Zithromax

13-03-2013

US pharma giant Merck & Co said yesterday that the Data Safety Monitoring Board (DSMB) of the IMPROVE-IT…

Antibiotics and Infectious diseasesCardio-vascularMerck & CoNorth AmericaPfizerPharmaceuticalRegulationResearchVytorinZithromax

Pfizer agrees $55 million settlement for off-label promotion of Protonix by Wyeth; strikes deal over Zyvox and Lyrica

13-12-2012

USA-based Pfizer (NYSE: PFE), the world's largest drugmaker by sales, has agreed to pay $55 million plus…

Antibiotics and Infectious diseasesFinancialGastro-intestinalsLegalLyricaMarkets & MarketingNeurologicalNorth AmericaPfizerPharmaceuticalProtonixWyethZyvox

US FDA should require Black Box warning for Pfizer’s antibiotic Tygacil, says Public Citizen

31-10-2011

US advocacy group Public Citizen has sent a petition to the Food and Drug Administration calling on the…

Antibiotics and Infectious diseasesNorth AmericaPfizerPharmaceuticalRegulationTygacil

Inconclusive Ph III results for Pfizer’s Vfend and Eraxis combo in fungal infections

03-10-2011

There was disappointing news for global drugs behemoth Pfizer (NYSE: PFE) last Friday, when the company…

Antibiotics and Infectious diseasesEraxisPfizerPharmaceuticalResearchVfend

Company Spotlight

ImmunoGen

ImmunoGen

Back to top